HRP Anti-SARS-CoV-2 nucleocapsid protein antibody [1A6] - Human IgG1 (Chimeric),Abcam,AB273168

Anti-SARS-CoV-2 nucleocapsid protein antibody [1A6] - Chimeric ( ab272852 ) is a recombinant human/mouse chimeric monoclonal antibody consisting of Mouse scFv fused with human IgG1. As the Fc region is human, an anti-Human secondary antibody should be used for detection.

Host

Human

Reactivity

SARS-CoV-2

Application

ELISA

Conjugate

HRP

Platform ID

BAB029973635

Abcam

Headquarters

Discovery Drive Cambridge Biomedical Campus Cambridge CB2 0AX UK

Contact

Tel: +44 (0)1223 696000
Fax: +44 (0)1223 215 215

Product Specifications
Scientific Background

Specifications

NameHRP Anti-SARS-CoV-2 nucleocapsid protein antibody [1A6] - Human IgG1 (Chimeric)
Cat. No.AB273168
HostHuman
IsotypeIgG1
ReactivitySARS-CoV-2
ConjugationHRP
ApplicationELISA
ClonalityMonoclonal
Clone Number1A6
Concentration0.33 - 0.42 mg/mL Batch dependent concentration
PurityAffinity purification
Appearance/FormLiquid
ShippingBlue Ice
FormulationpH: 7.4 Preservative: 0.03% Proclin 300 Constituents: PBS, 50% Glycerol (glycerin, glycerine)
Storage-20°C
Regulatory StatusResearch Use Only

Scientific Background

Target data Packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M (PubMed : 33264373). Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication. Attenuates the stress granules formation by reducing host G3BP1 access to host mRNAs under stress conditions (PubMed : 34901782, PubMed : 36534661).. May block host chemokine function in vivo, facilitating viral replication and transmission (PubMed : 35921414). Acts by being secreted into the extracellular space where it competes to host chemokines for binding to host glycosaminoglycans (GAG) (PubMed : 35921414).. May induce inflammasome responses in cultured cells and mice. Acts by interacting with host NLRP3 to facilitate inflammasome assembly, which induces cytokine release that may play a role in COVID lung injury. Disrupts the association betwen NLRP3 and ABHD8, enhancing NLRP3 stability and leading to increased inflammasome activation (PubMed : 39225180). See full target information N

Category Paths

Request a product

Please provide the required information below so that we can quickly source your products.